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Abstract
Background: The severe iatrogenic hypogonadal state induced by medical castration used for treatment of
prostate cancer is associated with adverse effects including fatigue, increased fracture risk, and a decrease in skeletal
muscle function, which negatively impact quality of life. We have previously reported beneficial changes in healthy
lifestyle behaviors, physical function and fatigue as a result of a novel combined exercise and dietary advice
intervention (a lifestyle intervention) in men with prostate cancer on androgen suppression therapy (AST). The aim
of this research was to conduct a qualitative evaluation of the lifestyle intervention in these men with advanced
prostate cancer receiving androgen suppression therapy (AST).
Methods: Twelve men with prostate cancer on AST took part in three focus groups in a UK higher education
institution following the 12 week intervention. Sessions lasted between 45 and 60 minutes in duration. All
discussions were audio-taped and transcribed. A framework analysis approach was applied to the focus group data.
An initial coding framework was developed from a priori issues listed in the topic guide and extended and refined
following initial familiarization with the focus group transcripts. Line by line indexing of the transcripts was
undertaken iteratively to allow for the incorporation of new codes. Coded sections of text were grouped together
(charted) into themes and subthemes prior to a further process of comparison and interpretation.
Results: None of the participants involved in the trial were provided with information on how lifestyle changes
might be beneficial to men with prostate cancer during the course of their standard medical treatment. We present
novel findings that this intervention was considered beneficial for reducing anxiety around treatment and fear of
disease progression. Men were supportive of the benefits of the intervention over conventional cancer survival
discussion group arrangements as it facilitated peer support in addition to physical rehabilitation.
Conclusions: The benefits of lifestyle changes in men with prostate cancer are not well appreciated by care
providers despite a range of benefits becoming apparent. Strategies to implement exercise and dietary
interventions in standard care should be further evaluated.
Trial registration: Current Controlled Trials ISRCTN88605738
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Background
There are more than two million cancer survivors in the
UK with this figure set to increase year on year [1]. Pros-
tate cancer is the most frequently diagnosed malignancy
in men, and medical castration through the use of an-
drogen suppression therapy (AST) is the mainstay of
treatment for advanced prostate cancer [2]. At present,
nearly 50% of all men diagnosed with prostate cancer
will undergo AST at some stage after diagnosis [3] and
men can remain on such treatment for up to two decades
[4]. The severe iatrogenic hypogonadal state induced by
medical castration is associated with adverse effects in-
cluding fatigue [5,6], increased fracture risk [7,8], and a
decrease in skeletal muscle function [5] which negatively
impact quality of life [9]. In the UK, The National Cancer
Survivorship Initiative has highlighted physical symp-
toms as a consequence of treatment as an area of
research with the highest priority [10]. We have previ-
ously reported beneficial changes in healthy lifestyle
behaviors, physical function and fatigue as a result of a
novel lifestyle intervention in men with prostate cancer
on AST [11]. However, what is still unclear is how these
men evaluate the experience of participating in the study
and what recommendations should be made for integrat-
ing it into practice. Understanding patient perspectives
of primary and adjunctive treatment are necessary to en-
able better cancer care [12]. Therefore, the aim of this
study was to conduct a qualitative evaluation of a prag-
matic supervised exercise program in combination with
dietary advice in men with advanced prostate cancer
on AST.
Methods
Patient details
Following ethical approval from South Sheffield Re-
search Ethics Committee, sedentary men with histologi-
cally confirmed, T3-T4 prostate cancer who had been
receiving AST for at least six months were identified
from outpatient clinics and randomized either to a com-
bined exercise and dietary advice intervention or to stan-
dard care. Those with unstable angina, uncontrolled
hypertension, recent myocardial infarction, pacemakers,
and painful or unstable bony metastases and those
already undertaking regular physical activity (men en-
gaging in purposeful exercise or physical activity of at
least a moderate intensity for 30 minutes or more, three
times per week) were excluded. Written informed con-
sent was obtained from each participant. Randomization
was carried out remotely, using nQuery statistical soft-
ware (nQuery Advisor 6.01; Statistical Solutions).
Trial details
Details of the intervention have been published else-
where previously [11]. Briefly, in addition to a tapered
supervised exercise program, a nutrition advice pack en-
couraging a reduction of saturated fat and refined carbo-
hydrate and an increase of dietary fiber intake with
moderation of alcohol was provided and small-group
healthy eating seminars, lasting approximately 15 to 20
minutes, were carried out fortnightly. The men in the
lifestyle intervention group showed improvements in ex-
ercise behavior (P <0.001), dietary fat intake (P = 0.001),
total energy intake (P = 0.005), fatigue (P = 0.002), aer-
obic exercise tolerance (P <0.001) and muscle strength
(P = 0.033) compared with standard care controls.
Focus group details
Three to six months following the intervention, patients
were invited to attend a focus group to share their
experiences of the lifestyle intervention retrospectively.
Three separate sessions involving a total of 12 men took
place in a private conference room at Sheffield Hallam
University. During the intervention men had been en-
couraged to attend the lifestyle program in groups to
facilitate social support and inter-individual encourage-
ment. It was felt that preserving the group structure
would be a valid approach to evaluating the experiences
of these men during the trial. One of the advantages of
focus groups over individual interviews is the group dy-
namics, that is, the type and range of data generated
through the social interaction of the group, can be dee-
per and richer than those obtained from one-on-one
interviews [13]. In particular, we were keen to see how
men would interact during the focus group. All men
were reassured at the start of the session that any views
expressed in the focus group would remain confidential.
At the start of the session, men were provided with a
briefing, reminding them inter alia, that there were no
‘right’ or ‘wrong’ answers to the questions and that con-
structive criticism was a valued part of the process. Care
was taken by both facilitators to ask men to expand on
areas of group discussion without using overtly leading
questions. The topic guide was used to introduce areas
for open discussion rather than to coerce the partici-
pants into specific answers. As this was not an externally
funded study, men were not financially compensated for
expenses incurred while taking part. Sessions lasted be-
tween 45 and 60 minutes in duration. The study authors
(LB and HC) facilitated discussion around a topic guide
(see Table 1) designed to explore both process and inter-
vention outcomes. All discussions were audio-taped and
transcribed before analysis.
Thematic framework analysis
The steps of the thematic framework analysis [14,15]
were as follows. The authors firstly read and re-read the
transcripts several times to become familiar with the
data. The second stage involved noting salient phrases
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from the data. The thematic coding framework was then
developed from a list of a priori issues listed in the topic
guide and the areas identified in stage two. Inductive
coding of the transcripts was conducted line by line.
Comparison of quotes was done both within and be-
tween the three transcripts. During this part of the ana-
lysis, a constant reference was made to the study aim.
Thematic categories were further developed by compar-
ing data within a category and by constant comparison
of the data across categories. This was done to ensure
the interpretations remain grounded in the data. These
categories were defined, shared and discussed between
the three authors (LB, RS and VN). Authors LB and RS
conducted parallel coding with a senior qualitative re-
searcher (VN) as a quality control measure. In addition,
to making sense of individual quotes, this stage included
looking at the relationship between the quotes and the
links between the data as a whole, to provide explana-
tions for the findings and overarching themes. Hence,
after an analysis of the transcripts, data were categor-
ized into these a priori themes, or new themes were
constructed.
Results
The themes that emerged can be broadly categorized
into two overarching categories of a process evaluation
of the trial and outcomes from taking part in the in-
tervention. Descriptive quotes from focus groups (FG1,
FG2, FG3) are also presented to illustrate the emergent
themes. Each is now considered.
Process themes
Motivations for taking part in the study
Participants were thankful for the invitation to take part
in the research as it was a potential way to get back into
regular exercise. The feeling of giving something back
to the staff that helped treat participants with their
condition and the feeling of contributing to improved
treatment for ‘future patients’ appeared to suggest an
altruistic reason for participation:
‘. . .I jumped at it. I’ve always tried to keep myself
reasonably fit but I’ve just lapsed that little bit over
the past few months for various reasons and it was a
way to get on to the exercise part of it. . .’ (FG3)
‘Every tiny bit of knowledge is beneficial to future
patients.’ (FG2)
Views about the supervised group design of the program
The university rehabilitation suite as a venue to exercise
was a popular choice as it appeared to motivate the men
to work hard and ‘get stuck in’. The participants unani-
mously wanted to exercise with each other and did not
want to involve or include their wives particularly. This
could suggest that the exercise facility was seen as a par-
ticularly ‘male’ environment. Given that these men were
all hypogonadal, the presence of their wives could com-
promise a shared sense of masculinity:
‘When I used to come through those doors I used to
think, now then we are going to get stuck in today! I
want to try and do better than I did last time. ‘(FG1)
‘Would prefer just us.’ (FG1)
‘No, I think being away from them [men’s wives] is
good, you need a rest from them every now and again.
I don’t mind banter and nagging. But I think you
would get through more without them.’ (FG2)
Table 1 Topic guide for focus groups
Process evaluation of the lifestyle intervention Outcomes from the lifestyle intervention
• Reasons for participation and reasons for apprehension • Perceived benefits of the lifestyle intervention
• Structure of the supervised exercise sessions • Perceived problems with the lifestyle intervention
• Engaging with the independent exercise sessions • Communication with health professionals
• Frequency, intensity and duration of exercise sessions • Burden of disease and treatment side-effects
• Contact with exercise specialists
• Comparison to a commercial gym environment
• Barriers to exercising
• Format of the dietary intervention
• Overall duration of the intervention
• Support from peers/family
• Comparison to conventional discussions groups
• Burden of trial assessments
• Recommendations for the design of future lifestyle interventions
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Perceived benefits of the social interaction within the
group-based program
Participants found that being in the company of others
living with a similar condition and exercising together
was useful. Some participants found discussion about
their condition with others a new and helpful experience,
and were disappointed when the program ended. Partici-
pants in focus group three mentioned that they would
have preferred an intervention of longer duration. The
following extracts exemplify the (entirely un-coerced) peer
support that was built over the course of the intervention:
‘If you are on your own you don’t know where you
are going, but when you talk to other people, you
have been through what they have, and it gets easier.’
(FG2)
‘I think the big disappointment is that the course
ended. . .I would have liked it to go a little longer. We
were able to discuss amongst ourselves how maybe we
were coping with the bit of a health problem that we
have. . . because being chauvinistic males we tend to
keep it to ourselves and not wish to maybe discuss
what the effects Zoladex can have and what condition
we find ourselves in. But when I’m amongst people
like this I feel safe and confident.’ (FG3)
Views on home-based section of the exercise program
Participants did not seem as keen to continue exercises
at home as they felt they would get easily distracted by
competing domestic priorities: others felt something was
amiss when in the second six weeks of the program they
were asked to exercise at home and visit the center only
once a week:
‘At home you would probably do it once but nobody
forces you the second time, but if you were coming
down here [to the University] you would definitely do
it. I still do it but some weeks, yes I have missed
training out at home, but not very much. You get
home and you say I have got to do this, but nobody
forces you a second time, then it comes to the rest of
the week and you think it just slips by.’ (FG2)
‘Felt as though something was missing in that second
6 weeks when we came just once a week.’ (FG1)
‘Doing it in a group [exercising], because at home,
you can always do it tomorrow can’t you?’ (FG1)
Perceived benefits from the diet aspect of the program
The majority of participants found aspects of the diet
education helpful. However, men also acknowledged
that they were not able to stick to the diet advice
consistently. Other statements were much more explicit
in advocating its benefits:
‘Sometimes I used to buy a lot more pre-prepared
meals from the supermarket. Not now. Not so
much.’(FG1)
‘I think dietary advice was really good - a lot of it. I am
not saying I stuck rigidly to it because I like a drink,
but generally speaking I found that quite effective. . . I
think that actually made me lose weight.’ (FG2)
Factors that could affect future program participation
Participation in the future would depend on whether the
program continued to be perceived as beneficial. It was
further highlighted that a group lifestyle intervention
would be a preferable peer support structure to a con-
ventional cancer survival discussion group format, which
these men did not consider to have comparable benefits:
‘I would do it [participate in an exercise program] as a
group [again], but there again you wouldn’t keep
coming in if you were going to get nothing out of it.
When we were doing the exercises we thought we
were getting something out of it. Just having these
talks [referring to group discussions], is not doing a
lot of good to us. We still want a bit back.’ (FG1)
Men reported they would continue with the lifestyle
changes if they perceived positive benefits in their health
and that they would receive reassurances from an exercise
specialist that there was continued improvement. This may
have been important to the men because in their experi-
ence, meetings with the consultant had always been brief
with little chance for discussion and feedback. Men
appeared in favor of discussing these issues with support
sisters as they did not feel so rushed at these appointments.
‘If I joined a gym and had a regime that we could
cope with and that made us feel better, would it be
possible to come back to see you or some other
physiologist that could say yes you are still at a fitness
level, it is benefitting you. You know what I mean.’
(FG2)
‘Well I tell you what those support sisters - I don’t see
the consultant I just see them. I spend at least 1/2 an
hour and they are never trying to rush me out of the
place. They don’t just want to get rid of you: but the
consultant, I have 30 seconds with him!’ (FG2)
Impact on exercise behavior after the intervention
Several participants joined a gym after the intervention
but some men were wary about continuing after the
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program. Participants suggested that gyms outside of the
center were not aware of the study, the program and the
patient group and, as such, they were reluctant to use
them. This suggests a lack of confidence in the existing
community exercise facilities to understand and cater
for the specific needs of men with prostate cancer on
AST. In addition to this the potential cost of member-
ship was also mentioned as a potential barrier:
‘I think I pay £28 per month which is a lot of money
out of the pension.’(FG1)
‘Yes, yes, it is too expensive to go the gym [consensus
of the group, yes] it would cost a fortune a week.’
(FG1)
‘I would think it [if local gyms were aware about the
study and the program and that patients would be
referred to another gym by researcher that] would be
[beneficial]. Providing it was affordable to us.’ (FG2)
Outcome themes
Disease recurrence
An unexpected finding was that men in all three groups
mentioned that the intervention helped reduce fear of
disease progression, adverse feelings associated with AST
injections and fears about mortality. Fear of recurrence
(that is, fear that cancer might return, progress or dis-
seminate) [16,17] is a specific emotional difficulty facing
some cancer survivors. It can be long standing and also
negatively impact quality of life [18]. Indeed, fear of re-
currence is prevalent in survivors of localized prostate
cancer, and significantly predicts worse mental health
related quality of life [19]. However, comparatively less is
known about how it affects men on AST or strategies to
ameliorate such problems:
‘It keeps your mind going and you are not thinking
stupid things in the sense of I’m going to die and you
can get on with your life and enjoy it....’ (FG3).
‘You don’t worry so much about prostate cancer. . .
since I stopped exercising I found aches and pains
which become more significant, whereas if I was
exercising I probably wouldn’t have them.’ (FG2)
‘You want to get switched on a keep fit program - so
you forget all about your injections and stuff like that,
well I did anyway. It made me more happy.’ (FG1)
Communication with healthcare professionals
According to the participants, they were not told any-
thing about lifestyle changes from nurses or consultants
previously and were unsure as to whether such
information should have been directly solicited. Partici-
pants, in general, felt that in addition to not having
enough time during appointments with the consultant,
times between follow-up appointments were also much
longer than they would have preferred. Unanimously,
participants were very much concerned about their pros-
tate specific antigen (PSA) levels:
‘No [there was no mention of lifestyle changes]. . .I
suppose one could have asked. . .once a year I see the
consultant, yes I could ask him, but your mind seems
to be on other things, i.e. what is your PSA level today
rather than asking. (FG3)
‘I think the answer rests in whose hands you are with,
in the hands of those nursing sisters they were a mine
of information and support and then when there was
some other complication arose and I saw the
consultant. Afterwards, I am looking forward to going
back to see them [the support sisters] again. But it is
the nature of life isn’t it. All consultants are different.’
(FG2)
‘It depends if you are in control (controlled PSA),
then six months isn't a long time. This gentleman is
doubling every time now (i.e. PSA is doubling), that 6
months it is a hell of a long time. Now in that 6
months if it goes something daft can you bring me
back again. It might be no, and you think, god if I had
come after 1 month they might have done something
for me. Everybody is different.’ (FG2)
‘I would like someone to tell me how it’s going - if it’s
alright, if its growing, if it’s getting better. . .’ (FG1)
Benefits and drawbacks from taking part in the
intervention
Participants in all focus groups perceived an improve-
ment in their physical and psychological well-being,
which is an anticipated finding given the positive quanti-
tative results in our previous trial reports [11]. Partici-
pants were satisfied with the intensity and progression of
exercises and readily engaged in goal setting. The follow-
ing extracts demonstrate how psychological wellbeing
and physical improvements went hand in hand:
‘I was satisfied actually but particularly with the
rowing because I finished up - not with winning any
record, but I felt good with doing 1,000 meters in 5
minutes.’ (FG2)
‘With exercise now I always go a bit further, I do push
it a bit more. If you do the exercises there is a reward,
I have managed to increase my arm strength I must
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admit but I do push myself a bit further than I used
to.’ (FG2)
‘I feel wonderfully well. . .the 12 weeks in effect did
me a power of good. In spite of thinking that for my
age of 77 I was reasonably fit at the end of 12 weeks I
know I was fit, fitter than previously.’ (FG 3)
However, there were men who believed that although
exercise had benefited them in several respects, exercis-
ing would not help ease their urological side-effects.
Such problems were much more of a concern to the in-
dividual in the extract below. It was their consideration
that these problems are not something that a lifestyle
intervention would help with:
‘I find it very difficult to say whether I feel my side
effects are less. I must admit there are some side
effects which I jolly well do not want to have and
which I am absolutely certain exercise can do nothing
about and I shall have to go back to the consultant
and say, look please can we talk about this and can we
make alterations. It is the [urological] side effects that
are more significant things in my life it is not the fact
that I have prostate cancer.’ (FG2)
Discussion
None of the participants involved in the trial were pro-
vided with information on how lifestyle changes might be
beneficial to men with prostate cancer during the course
of their standard medical treatment. This analysis of post-
intervention focus groups supports current evidence that
lifestyle changes in men with advanced prostate cancer are
beneficial [11,20,21]. Further, we present novel evidence
that this intervention ameliorated anxiety around treat-
ment and fear of disease progression. We also report men
with prostate cancer have a preference for exercise re-
habilitation over conventional discussion groups.
Our analysis should be interpreted in the context of
relevant limitations. These views are from 12 men who
were willing to be randomized in a clinical trial and as
such might not be representative of all men with pros-
tate cancer. Further research is needed to explore the
preferences of men who potentially have more severe
functional limitations: however, it should be noted that
our recruited sample included men with metastatic dis-
ease. Also, we were unable to include all 21 men who
finished the 12 week lifestyle intervention, due to limita-
tions in their availability, although our sample of 12 was
more than 50% of the cohort. The intervention was only
short in duration (for example, 12 weeks); ideally cancer
rehabilitation programs should be designed to provide
sustained support for healthy lifestyles and investigate
barriers and facilitators to sustained behavior change
during implementation of longer-term (12 month) inter-
ventions. However, to the authors’ knowledge this is the
first qualitative analysis of how men with prostate cancer
evaluate the experience of lifestyle changes and as such
represents a novel contribution to the knowledge base.
The potential for disease progression is a frequently
reported concern for cancer survivors [22] and this can
persist for more than five years after diagnosis [23]. In-
deed, PSA levels were a persistent concern for these
men. Fear of recurrence/progression has been theorized
to be variable in its intensity and potentially exacerbated
by imminent treatment follow-up appointments or med-
ical check-ups [24]. Men in the focus groups reported
that being involved in the rehabilitation program helped
take the focus away from fear of cancer recurrence and
also the unpleasant feelings associated with Zoladex
injections. This finding could support the implementa-
tion of the lifestyle interventions outside of a hospital
setting, possibly in the community or at a dedicated re-
habilitation facility where contact with exercise specia-
lists can be facilitated. Indeed, the supervision of exercise
sessions enabled the negotiation of individually tailored
goal setting between the exercise physiologist and the
participants, with appropriate continuous re-evaluation.
Such strategies used in conjunction with feedback to
guide training progression are well recognized as import-
ant strategies to help program adherence and also pro-
mote fitness gains [25,26]. Evidence from the focus
groups indicates that the men felt this process of setting
and achieving goals meant they were able to exert or
‘push’ themselves further than expected. This qualitative
data reported in the focus groups provides a useful con-
text from understanding some of the quantitative find-
ings of the trial [27]. Indeed, we reported significant
improvements in aerobic exercise tolerance, muscular
strength and functional capacity as a result of the life-
style intervention and clinically relevant improvements
in fatigue perception [11].
Advice regarding the benefits of lifestyle changes in
men with prostate cancer, was not provided as part of
standard Urology follow-up care. As the results of this
analysis have demonstrated, supportive evidence in favor
of healthy lifestyle changes (in parallel with similar find-
ings elsewhere) [20,21], should be passed on during rou-
tine clinical practice. These men were strongly supportive
of an exercise or lifestyle-based rehabilitation program
rather than a discussion and support group. Although
previous reports from a meta-analysis have indicated that
psychosocial interventions (including guided support
groups) are effective at improving overall quality of life in
cancer survivors, [28] our findings are similar to previous
qualitative research in other cancer cohorts indicating that
rehabilitation programs are often the patient’s preference
[29,30]. It is appropriate to draw parallels with the
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intervention format and the group cohesion often asso-
ciated with self-help or support groups [31,32]. Men
reported a sense of equality, confidence and peer support
and this was not necessarily an anticipated component of
the intervention design. As such, any discussion about dis-
ease processes or treatment adverse effects was developed
without coercion, and hence at a socially acceptable and
comfortable pace during the group sessions [30]. Further-
more, it should be noted that in contrast to other evidence
in cancer cohorts [33] these men expressed that they pre-
ferred not to have spousal support during the rehabilitation
programandthatagroupdemographicconsistingexclusively
ofmenwith prostate cancerwas also a preference.
Accruing observational evidence suggests that habitual
exercise could reduce disease progression and mortality
in men with prostate cancer. [34,35] If this is to be
tested through interventions in clinical trials, future re-
search should consider that although men found this
short-term experience beneficial, the mechanisms for
provision of rehabilitation facilities need to be considered.
Commercially available gym memberships were judged
too expensive by these men, many of whom subsist from
a pension. Long-term rehabilitation programs might have
to be delivered using existing health care resources. Al-
ternatively, community exercise facilities with subsidized
membership schemes would be appealing. A behavior
change support structure will also likely be required to
facilitate long-term lifestyle change adherence,which could
potentially be delivered at monthly intervals through ex-
isting consultations with cancer nurse specialists. Such
consultations should include evaluation of progress and
re-assessment of lifestyle goals as appropriate.
Conclusions
None of the participants involved in this study were pro-
vided with information on how lifestyle changes might
be beneficial to men with prostate cancer during the
course of their standard medical treatment. We present
novel findings that this intervention was considered
beneficial for reducing anxiety around treatment and
fear of disease progression. Men were supportive of the
benefits of the intervention over conventional discussion
group arrangements as it facilitated peer support in ad-
dition to physical rehabilitation. The benefits of lifestyle
changes in men with prostate cancer are not well appre-
ciated by care providers despite a range of benefits be-
coming apparent. Strategies to implement exercise and
dietary interventions in standard care should be evaluated.
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